MAXCYTE, INC. (MXCT) stock: key figures, P/E, revenue and dividend
Industrials · United States · ISIN US57777K1060
MAXCYTE, INC. financials
| Fiscal year | 2025 |
|---|---|
| Revenue | 33.03 m USD |
| Gross profit | 26.80 m USD |
| Operating income | -51.90 m USD |
| EBIT | -51.90 m USD |
| Net income | -44.63 m USD |
| Diluted EPS – continuing operations | -0.42 USD |
Full history since 2012, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About MAXCYTE, INC.
MaxCyte, Inc., a life sciences company, discovers, develops, and commercializes cell therapeutics in the United States and internationally. The company's products consists of ExPERT ATx, a static electroporation instrument for small to medium scale transfection; ExPERT STx, a flow electroporation for protein production and drug development, as well as expression of therapeutic targets for cell-based assays; ExPERT GTx, a flow electroporation for large scale transfection in therapeutic applications; and ExPERT VLx for very large volume cell-engineering. It also provides disposable processing assemblies (PAs) to process and electroporate cells; and accessories supporting PAs, such as electroporation buffer solution and software protocols. The company licenses and sells its instruments and technology; and sells its consumables to developers of cell therapies, as well as to pharmaceutical and biotechnology companies for use in drug discovery and development, and bio-manufacturing. The company has strategic partnership with VectorBuilder focused on co-developing a new gene delivery solution. MaxCyte, Inc. was incorporated in 1998 and is headquartered in Rockville, Maryland.
More stocks
- SPRUCE BIOSCIENCES, INC. (SPRB)
- EASY BIOInc (353810.KQ)
- Excelliance MOS (5299.TWO)
- Helixmith Co. Ltd (084990.KQ)
- Foghorn Therapeutics Inc. (FHTX)
- Lucara Diamond Corp (LUC.TO)
- Compagnie Lebon S.A. (ALBON.PA)
- STLLR Gold Inc. (STLR.TO)
- WW INTERNATIONAL, INC. (WW)
- Jyong Biotech Ltd. Ordinary Shares (MENS)
- KLX Energy Services Holdings, Inc. (KLXE)
- Nykode Therapeutics ASA (NYKD.OL)
Not investment advice. All data without warranty, price as of 29.10.2026. Details in the risk notice.